|Bid||104.62 x 900|
|Ask||104.27 x 800|
|Day's range||103.46 - 104.71|
|52-week range||61.19 - 104.71|
|Beta (5Y monthly)||0.67|
|PE ratio (TTM)||20.56|
|Earnings date||28 Oct 2021|
|Forward dividend & yield||1.72 (1.66%)|
|Ex-dividend date||01 Sep 2021|
|1y target est||91.29|
Synchrony Financial's (SYF) third-quarter results benefit on the back of improved purchase volume and reduced expenses.
Zacks.com featured highlights include: Regeneron Pharm, Evercore, Houlihan Lokey and DICK'S Sporting Goods
Regeneron Pharmaceuticals (REGN), Evercore (EVR), Houlihan Lokey (HLI) & DICK'S Sporting Goods (DKS) currently have striking earnings growth and positive estimate revisions, which make them must-buys.